Virginia delegation urges Air Force to locate cyber operations squadron at Joint Base Langley-Eustis

AFP

U.S. Sens. Mark R. Warner (D-VA) and Tim Kaine (D-VA) along with U.S. Reps. Scott Rigell (R-VA-2), Bobby Scott (D-VA-3), Gerry Connolly (D-VA-11), Rob Wittman (R-VA-1), and Randy Forbes (R-VA-4), requested that the Air Force Space Command strongly consider locating a Cyber Operations Squadron (COS) at Joint Base Langley-Eustis (JBLE).

Warner, Portman introduce bill to increase college access for low-income students

Chris Graham

U.S. Senators Mark R. Warner (D-VA) and Rob Portman (R-OH) introduced bipartisan legislation, the Go To High School, Go To College Act, which will increase college access for low-income students by allowing them to earn college credits in high school through the Pell Grant program.

Ayotte, Warner reintroduce legislation in Senate to prevent horse soring

Chris Graham

U.S. Sens. Kelly Ayotte (R-NH) and Mark Warner (D-VA) today reintroduced legislation to protect horses from the abusive practice known as soring – in which show horse trainers apply blistering or burning agents, lacerations, sharp objects, or other substances or devices to a horse’s limb to intentionally make each step painful, forcing a horse to perform an exaggerated high-stepping gait that is rewarded in show rings.

Senators announce major step toward construction of embassy security training facility at Fort Pickett

Chris Graham

U.S. Senators Mark Warner and Tim Kaine along with U.S. Representatives Randy Forbes and Robert Hurt announced that the U.S. Department of State has completed the Final Environmental Impact Statement (FEIS) for the Foreign Affairs Security Training Center (FASTC) at Fort Pickett in Nottoway County.

tim kaine

Kaine introduces legislation to ensure careful review of new opiod drugs

AFP

This week, U.S. Senator Tim Kaine introduced the FDA Accountability for Public Safety Act, bipartisan legislation that would hold the U.S. Food and Drug Administration (FDA) accountable for the approval of new opioid drugs, ensuring experts’ voices are heard as new and potentially dangerous opioid medications are considered for approval.